by AVR Supporters | Sep 6, 2022 | News, Research
ORIA Grant Progress Report 2019-2020 Title: A new drug to control scarring after glaucoma surgery Investigator: Dr Elsa Chan Co-investigators: Dr Manisha Shah, Dr Jennifer Fan Gaskin Aim:Toevaluate the anti-scarring properties of 3ʼ,4ʼ-dihydroxyflavonol (DiOHF) in...
by AVR Supporters | Aug 8, 2022 | Research
A Perth Eye Foundation grant recipient Chief investigator: Dr Jason Charng Co-investigators: Dr David Alonso-Caneiro, Prof David Mackey Eyes with retinitis pigmentosa (RP) show a characteristic hyperautofluorescent ring (HAR) with fundus autofluorescence (FAF)...
by AVR Supporters | Jul 8, 2022 | Research
Last year, Dr Elisa Cornish (Chief Investigator) and A/Prof Samantha Fraser-Bell (Other Investigator) received a Priming Grant to the value of $50,000 for their work titled “Near-infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema” In...
by AVR Supporters | Feb 1, 2021 | Research
Dr Stuart Keel, Centre for Eye Research Australia, University of Melbourne, Victoria Up to 500,000 adults in Australia have vision impairment or blindness but it is estimated that 80% of vision loss is avoidable through early detection, prevention and treatment...
by AVR Supporters | Feb 1, 2021 | Research
Dr Fred Chen, Centre for Ophthalmology and Visual Science (Lions Eye Institute), The University of Western Australia Retinitis pigmentosa (RP) is an inherited eye condition that causes the light-sensitive cells at the back of the eye to slowly degenerate. RP affects 1...
by AVR Supporters | Feb 1, 2021 | Research
Dr Nilisha Fernando, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT Age-Related Macular Degeneration (AMD) is the leading cause of vision loss in the Western world. “There are two forms of the disease, ‘wet’...